Lexicon Pharmaceuticals, Inc.

LXRXNASDAQUSD
2.02 USD
0.01 (0.25%)🟢LIVE (AS OF 03:23 PM EDT)
🟢Market: OPEN

Lexicon Pharmaceuticals, Inc. (LXRX) trades at $2.02 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Sep 15, 2026.

Open?$2.01
High?$2.06
Low?$1.96
Prev. Close?$2.01
Volume?1.5M
Avg. Volume?2.7M
VWAP?$2.02
Rel. Volume?0.56x
Bid / Ask
Bid?$2.02 × 26.3K
Ask?$2.03 × 18.8K
Spread?$0.01
Midpoint?$2.03
Valuation & Ratios
Market Cap?894.4M
Shares Out?445.0M
Float?226.4M
Float %?50.9%
P/E Ratio?N/A
P/B Ratio?5.12
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Employees
81
Market Cap
894.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2000-04-07
Address
2445 TECHNOLOGY FOREST BLVD.
THE WOODLANDS, TX 77381
Phone: (281) 863-3000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
10
Short Sent.?
53
Piotroski F-Score?2/9Weak
Altman Z-Score?-4.08Distress
Confidence?62%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.02%High
Short Interest?29.5M
Days to Cover?10.3
Free Float226.4M
Avg Daily Volume2.9M
Settlement Date2026-08-31
Financial Health
Current Ratio?13.37Strong
Quick Ratio?13.29Strong
Cash Ratio?2.78Strong
Debt/Equity?0.29Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A
P/B?
Peers
100
S&P
36
5.12FAIR
P/S?
Peers
100
S&P
3
21.65HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-16.2CHEAP
EV/Sales?
Peers
100
S&P
3
21.90HIGH
Returns & Efficiency
ROE?
S&P
5
-35.0%WEAK
ROA?
S&P
3
-24.4%WEAK
Cash Flow & Enterprise
FCF?$-64988000
Enterprise Value?$904.9M
Fundamentals ratios updated end of day